Group 1 - China Tianyi has received approval for the second phase expansion of the Phu Son waste-to-energy plant in Hanoi, Vietnam, with a capacity of 1,600 tons/day and an investment of approximately $220 million [2] - Palm Holdings is facing a lawsuit for 113 million yuan due to a construction contract dispute, which represents 6.83% of the company's latest audited net assets [3] - Huazhi Media's film "Silent Awakening" has grossed over 900 million yuan, exceeding 50% of the company's latest annual revenue, although it will not impact revenue recognition until costs are recovered [4] Group 2 - Duori Pharmaceutical's tender offer period has expired, and its stock will be suspended from trading starting February 25, 2026 [5] - Dazhu Laser plans to invest $150 million to establish an overseas operation center in Southeast Asia to enhance service capabilities [6] - Dongyangguang is planning to issue shares to acquire control of Yichang Dongshu No. 1 Investment Co., with trading suspended for up to 10 trading days [7] Group 3 - Weidao Nano reported a net profit of 213 million yuan for 2025, a decrease of 6.12% year-on-year, attributed to reduced acceptance of photovoltaic equipment [9] - Zhongke Shuguang's net profit for 2025 increased by 11% to 2.113 billion yuan, driven by improved product structure and operational efficiency [10] - San Sheng Guojian's net profit surged by 317.09% to 2.939 billion yuan, largely due to a significant collaboration with Pfizer [11] Group 4 - Wens Foodstuff's net profit for 2025 fell by 43.59% to 5.235 billion yuan, impacted by declining prices in pork and chicken sales [12] - Yishi Precision achieved a net profit of 59.89 million yuan, up 10.70%, supported by stable revenue growth and effective cost management [13] - Supor's net profit decreased by 6.58% to 2.097 billion yuan, despite a slight revenue increase due to competitive market conditions [14] Group 5 - Jiaokong Technology's net profit rose by 86.13% to 156 million yuan, driven by increased deliveries [15] - Zhongwei Semiconductor reported a net profit of 285 million yuan, up 108.05%, benefiting from sustained R&D investment and product expansion [17] - Aidi Pharmaceutical reported a revenue increase of 72.49% to 721 million yuan, but still incurred a net loss of 19.73 million yuan [18] Group 6 - Fanwei Network plans to repurchase and cancel 4.2371 million shares from its 2023 employee stock ownership plan due to unmet performance targets [20] - Yashiguangdian's major shareholder plans to reduce holdings by up to 1.6 million shares due to personal financial needs [22] - Shaoneng's subsidiary signed a significant contract worth 22 million yuan for a biomass power generation project [24]
晚间公告|2月24日这些公告有看头
Di Yi Cai Jing·2026-02-24 10:15